Search Results - "Cummins, Martin J"

Mini-Dose Glucagon as a Novel Approach to Prevent Exercise-Induced Hypoglycemia in Type 1 Diabetes by Rickels, Michael R, DuBose, Stephanie N, Toschi, Elena, Beck, Roy W, Verdejo, Alandra S, Wolpert, Howard, Cummins, Martin J, Newswanger, Brett, Riddell, Michael C

“…Patients with type 1 diabetes who do aerobic exercise often experience a drop in blood glucose concentration that can result in hypoglycemia. Current…”
Get full text

A Randomized, Placebo-Controlled Double-Blind Trial of a Closed-Loop Glucagon System for Postbariatric Hypoglycemia by Mulla, Christopher M, Zavitsanou, Stamatina, Laguna Sanz, Alejandro Jose, Pober, David, Richardson, Lauren, Walcott, Pamela, Arora, Ipsa, Newswanger, Brett, Cummins, Martin J, Prestrelski, Steve J, Doyle, Francis J, Dassau, Eyal, Patti, Mary Elizabeth

“…Abstract Background Postbariatric hypoglycemia (PBH) can threaten safety and reduce quality of life. Current therapies are incompletely effective. Methods…”
Get full text

Nonaqueous, Mini-Dose Glucagon for Treatment of Mild Hypoglycemia in Adults With Type 1 Diabetes: A Dose-Seeking Study by Haymond, Morey W, Redondo, Maria J, McKay, Siripoom, Cummins, Martin J, Newswanger, Brett, Kinzell, John, Prestrelski, Steven

“…To evaluate mini-dose glucagon in adults with type 1 diabetes using a stable, liquid, ready-to-use preparation. Twelve adults with type 1 diabetes receiving…”
Get full text

Oromucosal Administration of Interferon to Humans by Beilharz, Manfred W, Cummins, Martin J, Bennett, Alayne L, Cummins, Joseph M

“…The prevailing dogma is that, to be systemically effective, interferon-alpha (IFNα) must be administered in sufficiently high doses to yield functional blood…”
Get full text

Efficacy and Safety of Mini-Dose Glucagon for Treatment of Nonsevere Hypoglycemia in Adults With Type 1 Diabetes by Haymond, Morey W, DuBose, Stephanie N, Rickels, Michael R, Wolpert, Howard, Shah, Viral N, Sherr, Jennifer L, Weinstock, Ruth S, Agarwal, Shivani, Verdejo, Alandra S, Cummins, Martin J, Newswanger, Brett, Beck, Roy W

“…Standard treatment of hypoglycemia is oral carbohydrate, but it often results in hyperglycemia and entails extra caloric intake. To evaluate low-dose glucagon…”
Get full text

Low-dose oral interferon α possibly retards the progression of idiopathic pulmonary fibrosis and alleviates associated cough in some patients by Lutherer, Lorenz O, Nugent, Kenneth M, Schoettle, Byron W, Cummins, Martin J, Raj, Rishi, Birring, Surinder S, Jumper, Cynthia A

Get more information

Low‐dose oral interferon alpha as prophylaxis against viral respiratory illness: a double‐blind, parallel controlled trial during an influenza pandemic year by Bennett, Alayne L., Smith, David W., Cummins, Martin J., Jacoby, Peter A., Cummins, Joseph M., Beilharz, Manfred W.

“…Background and objective Interferon alpha (IFNα) is a known antiviral agent. A double‐blind, placebo‐controlled clinical trial was conducted investigating the…”
Get full text

Low-dose oral use of human interferon-alpha in cancer patients by Cummins, M J, Pruitt, B

“…In a double-blind placebo-controlled trial, 57 adult subjects with disseminated malignancies were given orally low doses of recombinant human interferon-alpha…”
Get more information

Treatment of primary sjögren's syndrome with low‐dose human interferon alfa administered by the oromucosal route: Combined phase III results by Cummins, Martin J., Papas, Athena, Kammer, Gary M., Fox, Philip C.

“…Objective This study tested the safety and efficacy of human interferon (IFN) alfa for treatment of salivary hypofunction and dry mouth symptoms in primary…”
Get full text

Liquid Room Temperature Stable Glucagon—Glucose Response in Pediatric Type 1 Diabetes Patients by BUCKINGHAM, BRUCE, CUMMINS, MARTIN J., PRESTRELSKI, STEVEN J., STRANGE, POUL

“…Objective: The International Society for Pediatric and Adolescent Diabetes recommends age-specific dosing of glucagon for the rescue of severe hypoglycemia. A…”
Get full text

384-P: An Integrated Summary of Safety and Efficacy of a Ready-to-Use Liquid Glucagon Rescue Pen for the Treatment of Severe Hypoglycemia in Adults by CHRISTIANSEN, MARK P., CUMMINS, MARTIN J., PRESTRELSKI, STEVEN J., JUNAIDI, MOHAMMED K.

“…Objective: To prevent medical complications of severe hypoglycemic emergencies, prompt and reliable rescue intervention is critically important. A ready-to-use…”
Get full text

A Phase 3 Comparison of a Novel Liquid Glucagon Autoinjector to Glucagon Emergency Kit for the Treatment of Severe Hypoglycemia by CHRISTIANSEN, MARK P., CUMMINS, MARTIN J., PRESTRELSKI, STEVEN J., STRANGE, POUL

“…Objective: To prevent medical complications and serious sequalae of severe hypoglycemic emergencies, prompt and reliable rescue intervention is critically…”
Get full text

A Phase 3 Comparison of a Novel Liquid Glucagon Autoinjector to Glucagon Emergency Kit for the Symptomatic Relief of Severe Hypoglycemia by CHRISTIANSEN, MARK P., CUMMINS, MARTIN J., STEVEN J., PRESTRELSKI, STRANGE, POUL

“…Objective: A novel ready-to-use stable liquid glucagon autoinjector (GAI; Xeris Pharmaceuticals), was evaluated for relief of symptoms during rescue treatment…”
Get full text

A third study on the use of orally administered anhydrous crystalline maltose for relief of dry mouth in primary Sjögren's syndrome by Fox, Philip C, Cummins, Martin J, Cummins, Joseph M

“…To examine the safety and efficacy of anhydrous crystalline maltose for treatment of dry mouth and other symptoms of dryness in patients with primary Sjögren's…”
Get more information

Efficacy and Safety of Mini-dose Glucagon for Treatment of Non-severe Hypoglycemia in Adults with Type 1 Diabetes by Haymond, Morey W, DuBose, Stephanie N, Rickels, Michael R, Wolpert, Howard, Shah, Viral N, Sherr, Jennifer L, Weinstock, Ruth S, Agarwal, Shivani, Verdejo, Alandra S, Cummins, Martin J, Newswanger, Brett, Beck, Roy W

Get full text

Use of orally administered anhydrous crystalline maltose for relief of dry mouth by Fox, P C, Cummins, M J, Cummins, J M

“…To examine the safety and efficacy of anhydrous crystalline maltose (ACM) for treatment of dry mouth. ACM was delivered orally as a 200-mg lozenge given three…”
Get more information

Dry mouth--a new treatment choice by Fox, Philip C, Cummins, Martin J

“…Treatment with a new formulation of a simple carbohydrate provides significant relief for dry mouth sufferers. Lozenges of the new treatment Salive given three…”
Get full text